161 related articles for article (PubMed ID: 7333719)
1. Immune response modifying activity in mice of polyinosinic: polycytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly-ICLC].
Chirigos MA; Papademetriou V; Bartocci A; Read E; Levy HB
Int J Immunopharmacol; 1981; 3(4):329-37. PubMed ID: 7333719
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
Talmadge JE; Adams J; Phillips H; Collins M; Lenz B; Schneider M; Schlick E; Ruffmann R; Wiltrout RH; Chirigos MA
Cancer Res; 1985 Mar; 45(3):1058-65. PubMed ID: 3155990
[TBL] [Abstract][Full Text] [Related]
3. Interferon induction in piglets with polyinosinic:polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
Loewen KG; Derbyshire JB
Res Vet Sci; 1988 Jan; 44(1):132-3. PubMed ID: 2453906
[TBL] [Abstract][Full Text] [Related]
4. Activation of natural killer cells in newborn piglets by interferon induction.
Lesnick CE; Derbyshire JB
Vet Immunol Immunopathol; 1988 Mar; 18(2):109-17. PubMed ID: 2838948
[TBL] [Abstract][Full Text] [Related]
5. Biological characterization of MVE-2 and poly ICLC.
Schlick E; Welker R; Piccoli M; Ruffmann R; Chirigos M
Prog Clin Biol Res; 1984; 161():511-24. PubMed ID: 6483902
[No Abstract] [Full Text] [Related]
6. Hyporeactivity to interferon induction in newborn piglets.
Derbyshire JB; Lesnick CE
J Interferon Res; 1990 Feb; 10(1):47-53. PubMed ID: 1691769
[TBL] [Abstract][Full Text] [Related]
7. Enhanced induction of plasma interferon after subcutaneous administration in rabbits of poly ICLC with albumin.
Pessina GP; Muscettola M; Paulesu L; Bocci V
J Biol Regul Homeost Agents; 1989; 3(3):118-21. PubMed ID: 2483023
[TBL] [Abstract][Full Text] [Related]
8. Tumor response to interferon inducer and radiation effect of serum interferon levels.
Lvovsky EA; D'Souza J; Eng D; D'Souza D; Lvovsky B; Hetland R; Craver WL; Sobel SH
J Biol Regul Homeost Agents; 1988; 2(1):1-6. PubMed ID: 2459908
[TBL] [Abstract][Full Text] [Related]
9. Poly ICLC induces anti-IC antibodies in mice and rabbits.
Granados EN; Alm T; O'Malley JA; McGarry M; Bello J
J Interferon Res; 1984; 4(1):57-62. PubMed ID: 6715915
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and therapeutic activity of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethylcellulose [poly(I,C)-LC].
Chirigos MA; Schlick E; Ruffmann R; Budzynski W; Sinibaldi P; Gruys E
J Biol Response Mod; 1985 Dec; 4(6):621-7. PubMed ID: 4087033
[TBL] [Abstract][Full Text] [Related]
11. Interferon induction by and toxicity of polyriboinosinic acid [poly(rI)].polyribocytidylic acid [poly (rC)], mismatched analog poly (rI).poly[r(C12Uracil)n], and poly(rI).poly(rC) L-lysine complexed with carboxymethylcellulose.
Stringfellow DA; Weed SD
Antimicrob Agents Chemother; 1980 Jun; 17(6):988-92. PubMed ID: 6157363
[TBL] [Abstract][Full Text] [Related]
12. The kinetics of interferon induction by poly ICLC in humans.
Bever CT; McFarland HF; McFarlin DE; Levy HB
J Interferon Res; 1988 Aug; 8(4):419-25. PubMed ID: 2459270
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator.
Peters CJ; Reynolds JA; Slone TW; Jones DE; Stephen EL
Antiviral Res; 1986 Aug; 6(5):285-97. PubMed ID: 2429616
[TBL] [Abstract][Full Text] [Related]
14. Double-stranded RNA regulation of DNA synthesis in fibroblasts.
Perricone MA; Giri SN; Hyde DM
Exp Cell Res; 1992 Jan; 198(1):101-6. PubMed ID: 1727043
[TBL] [Abstract][Full Text] [Related]
15. Dose and regimen effects of poly ICLC, an interferon inducer, in a multi-dose bleomycin model of interstitial pulmonary fibrosis.
Wild JS; Hyde DM; Giri SN
Pharmacol Toxicol; 1994 Jul; 75(1):42-8. PubMed ID: 7526360
[TBL] [Abstract][Full Text] [Related]
16. [Effect of interferon inducer (poly ICLC) in the treatment of malignant brain tumor (author's transl)].
Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
No To Shinkei; 1982 Mar; 34(3):267-73. PubMed ID: 7093065
[TBL] [Abstract][Full Text] [Related]
17. Vaccine adjuvant effects, and immune response, to synthetic polymers MVE and poly ICLC.
Chirigos MA; Welker R; Schlick E; Saito T; Ruffmann R
Prog Clin Biol Res; 1984; 161():467-79. PubMed ID: 6483899
[No Abstract] [Full Text] [Related]
18. Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects.
Ewel CH; Urba WJ; Kopp WC; Smith JW; Steis RG; Rossio JL; Longo DL; Jones MJ; Alvord WG; Pinsky CM
Cancer Res; 1992 Jun; 52(11):3005-10. PubMed ID: 1591717
[TBL] [Abstract][Full Text] [Related]
19. Effect of tumor burden and route of administration on the immunotherapeutic properties of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethyl cellulose [Poly(I,C)-LC].
Black PL; Hartmann D; Pennington R; Phillips H; Schneider M; Tribble HR; Talmadge JE
Int J Immunopharmacol; 1992 Nov; 14(8):1341-53. PubMed ID: 1464467
[TBL] [Abstract][Full Text] [Related]
20. Immune modulating effects of poly ICLC.
Levy HB; Lvovsky E; Riley F; Harrington D; Anderson A; Moe J; Hilfenhaus J; Stephen E
Ann N Y Acad Sci; 1980; 350():33-41. PubMed ID: 6972185
[No Abstract] [Full Text] [Related]
[Next] [New Search]